Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response.

[1]  A. Azad,et al.  Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. , 2008, Journal of immunology.

[2]  V. Bowles,et al.  Biomedical applications of sheep models: from asthma to vaccines. , 2008, Trends in biotechnology.

[3]  R. Homer,et al.  Developmental regulation of NO-mediated VEGF-induced effects in the lung. , 2008, American Journal of Respiratory Cell and Molecular Biology.

[4]  A. Jobe,et al.  Toll-Like Receptors and Agonist Responses in the Developing Fetal Sheep Lung , 2008, Pediatric Research.

[5]  M. Ferguson-Smith,et al.  Mammalian karyotype evolution , 2007, Nature Reviews Genetics.

[6]  Melonie P. Heron,et al.  Deaths: leading causes for 2004. , 2007, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[7]  Eliza H. Myers,et al.  Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. , 2007, The Cochrane database of systematic reviews.

[8]  D. Hommes,et al.  Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists , 2007, Molecular and Cellular Endocrinology.

[9]  Motoko Takahashi,et al.  Pulmonary collectins in innate immunity of the lung , 2007, Cellular microbiology.

[10]  R. Schleimer,et al.  Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins1 , 2007, The Journal of Immunology.

[11]  F. Miot,et al.  Developmental regulation of DUOX1 expression and function in human fetal lung epithelial cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[12]  P. Giavina-Bianchi,et al.  Specific IgE against recombinant allergens in allergic bronchopulmonary aspergillosis. , 2007, American journal of respiratory and critical care medicine.

[13]  D. Meyerholz,et al.  Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection. , 2007, Viral immunology.

[14]  S. Randell,et al.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis , 2007, FEBS letters.

[15]  J. Zabner,et al.  A novel host defense system of airways is defective in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[16]  Jack M. Gallup,et al.  Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions , 2006, Biological Procedures Online.

[17]  D. Meyerholz,et al.  Monocytic/Macrophagic Pneumonitis after Intrabronchial Deposition of Vascular Endothelial Growth Factor in Neonatal Lambs , 2006, Veterinary pathology.

[18]  M. Kamran,et al.  Surfactant proteins SP-A and SP-D: structure, function and receptors. , 2006, Molecular immunology.

[19]  Bernard Guyer,et al.  Annual Summary of Vital Statistics—2003 , 2005, Pediatrics.

[20]  O. Baud,et al.  Benefit of antenatal glucocorticoids according to the cause of very premature birth , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[21]  A. Jobe,et al.  Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[22]  J. Whitsett,et al.  Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. , 2004, American journal of respiratory cell and molecular biology.

[23]  J. Whitsett,et al.  VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[24]  M. Hallman,et al.  Changing incidence and outcome of infants with respiratory distress syndrome in the 1990s: a population‐based survey , 2004, Acta paediatrica.

[25]  K. Chung,et al.  Inhibition of chemokine production from human airway smooth muscle cells by fluticasone, budesonide and beclomethasone. , 2004, Pulmonary pharmacology & therapeutics.

[26]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[27]  P. Foster,et al.  Chemokines in asthma: cooperative interaction between chemokines and IL-13. , 2003, The Journal of allergy and clinical immunology.

[28]  Jiahuai Han,et al.  Inhibition of p38 MAPK by Glucocorticoids via Induction of MAPK Phosphatase-1 Enhances Nontypeable Haemophilus influenzae-induced Expression of Toll-like Receptor 2* , 2002, The Journal of Biological Chemistry.

[29]  N. Voelkel,et al.  Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[30]  J. Whitsett,et al.  The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. , 2002, The Journal of clinical investigation.

[31]  D. Franchimont,et al.  Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[33]  S. Abman.  Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.

[34]  J. Dunphy,et al.  Isolation, characterisation and expression of mRNAs encoding the ovine CC chemokines, monocyte chemoattractant protein (MCP)-1alpha and -2. , 2001, Veterinary immunology and immunopathology.

[35]  K. Goss,et al.  VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[36]  P. McCray,et al.  The Ovine Cathelicidin SMAP29 Kills Ovine Respiratory Pathogens In Vitro and in an Ovine Model of Pulmonary Infection , 2001, Antimicrobial Agents and Chemotherapy.

[37]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[38]  S. Abbasi,et al.  Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. , 2000, American journal of obstetrics and gynecology.

[39]  S. Varsano,et al.  Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line , 2000, Thorax.

[40]  P. Sly,et al.  Pediatric Respiratory Medicine , 1999 .

[41]  L. M. Berry,et al.  Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. , 1998, American journal of obstetrics and gynecology.

[42]  S. Dunlop,et al.  Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. , 1997, The Journal of maternal-fetal medicine.

[43]  P. Sly,et al.  Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. , 1997, American journal of respiratory and critical care medicine.

[44]  R. Schleimer,et al.  The epithelium as a target of glucocorticoid action in the treatment of asthma. , 1996, American journal of respiratory and critical care medicine.

[45]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[46]  P. Crowley.  Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. , 1995, American journal of obstetrics and gynecology.

[47]  J. Ripoche,et al.  Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. , 1995, Clinical and experimental immunology.

[48]  A. Whitehead,et al.  The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.

[49]  P. Muñoz-Cánoves,et al.  Analysis of complement factor H mRNA expression: dexamethasone and IFN-gamma increase the level of H in L cells. , 1989, Biochemistry.

[50]  H. Harding,et al.  Postnatal stimulation of rat surfactant protein A synthesis by dexamethasone. , 1989, The American journal of physiology.

[51]  D. Kreutzer,et al.  Effect of lipopolysaccharide on C3 and C5 production by human lung cells. , 1989, Journal of immunology.

[52]  R. Strunk,et al.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. , 1988, The Journal of clinical investigation.

[53]  I. Findlay.  Respiratory disorders of the newborn. , 1970, UNA nursing journal.

[54]  S. Harigopal,et al.  Respiratory Disorders of the Newborn , 2009 .

[55]  B. Bánfi.  A novel host defense system of airways is defective in cystic fibrosis: update. , 2007, American journal of respiratory and critical care medicine.

[56]  R. Schleimer.  Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. , 2004, Proceedings of the American Thoracic Society.

[57]  P. Carmeliet,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[58]  R. Rodriguez.  Respiratory distress syndrome and its management , 2002 .

[59]  S. Boas,et al.  Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. , 2000, American journal of respiratory and critical care medicine.

[60]  J. Newnham,et al.  Repeated antenatal corticosteroids: size at birth and subsequent development. , 1999, American journal of obstetrics and gynecology.

[61]  R. Goldenberg,et al.  A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. , 1993, American journal of obstetrics and gynecology.

[62]  E. Weibel,et al.  Structural alterations of lung parenchyma in the adult respiratory distress syndrome. , 1982, Clinics in chest medicine.

[63]  A. Fanaroff,et al.  Neonatal-perinatal medicine: Diseases of the fetus and infant , 1977 .

[64]  E. Cooper.  Why developmental and comparative immunology , 1977 .

[65]  W. Thurlbeck.  Postnatal growth and development of the lung. , 1975, The American review of respiratory disease.